These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6667821)

  • 1. [Platelet antiaggregants in post-myocardial infarct patients: why, which and in what doses?].
    Mannucci PM
    G Ital Cardiol; 1983 Nov; 13(11):335-9. PubMed ID: 6667821
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet antiaggregants: review of the literature (author's transl)].
    Sternon J
    Rev Med Brux; 1981 May; 2(5):487-92. PubMed ID: 7020033
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
    Oelz O
    Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
    Verdecchia P
    G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
    [No Abstract]   [Full Text] [Related]  

  • 5. [Strategies for antiplatelet therapy-drug-fixed method and suppression-fixed method].
    Hattori A
    Nihon Rinsho; 1992 Feb; 50(2):385-91. PubMed ID: 1613995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct].
    Rühle H
    Z Arztl Fortbild (Jena); 1985; 79(11):463-6. PubMed ID: 3901541
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombocyte function and the repair of myocardial infarct].
    Kinoshenko EI; Aliavi AL; Vlasenko MA
    Vrach Delo; 1989 Jan; (1):27-9. PubMed ID: 2718437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulants and platelet-inhibiting drugs in stroke.
    Corn M
    Am Fam Physician; 1977 Sep; 16(3):77-8. PubMed ID: 900011
    [No Abstract]   [Full Text] [Related]  

  • 9. [Aftercare of heart infarct patients to reduce the risk of a subsequent infarction].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1983 Apr; 127(16):673-9. PubMed ID: 6134240
    [No Abstract]   [Full Text] [Related]  

  • 10. [Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
    Schröder R
    Dtsch Med Wochenschr; 1981 Apr; 106(17):546-53. PubMed ID: 6111439
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
    Thiele R
    Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet aggregation and atherosclerosis.
    Valladares BK; Lemberg L
    Heart Lung; 1986 Mar; 15(2):211-4. PubMed ID: 3633253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet drugs after myocardial infarction.
    Med Lett Drugs Ther; 1980 Mar; 22(6):25-6. PubMed ID: 7360108
    [No Abstract]   [Full Text] [Related]  

  • 14. [Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct].
    Di Pasquale G; Ottani F; Ceré E; Biancoli S; Sassone B; Lombardi A
    Recenti Prog Med; 1998 Oct; 89(10):514-9. PubMed ID: 9842255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of therapy with platelet antiaggregants for threatened stroke.
    The Canadian Cooperative Stroke Study Group
    Can Med Assoc J; 1980 Feb; 122(3):293-6. PubMed ID: 6989457
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sulfinpyrazone (Anturane)--new indication: myocardial infarct?].
    Bolte HD
    MMW Munch Med Wochenschr; 1980 Apr; 122(14):507-8. PubMed ID: 6769029
    [No Abstract]   [Full Text] [Related]  

  • 17. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiplatelet drugs after acute myocardial infarction.
    Mannucci PM
    Ric Clin Lab; 1984; 14(1):1-7. PubMed ID: 6729352
    [No Abstract]   [Full Text] [Related]  

  • 19. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 20. Preventing death after myocardial infarction.
    Horwitz DL
    Compr Ther; 1980 Jun; 6(6):3-4. PubMed ID: 7379491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.